UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$646M |
| 2 |
Automatic Data Processing
ADP
|
+$510M |
| 3 |
Baidu
BIDU
|
+$349M |
| 4 |
Tesla
TSLA
|
+$320M |
| 5 |
NVIDIA
NVDA
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$758M |
| 2 |
Shopify
SHOP
|
+$568M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$521M |
| 4 |
Microsoft
MSFT
|
+$515M |
| 5 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$403M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.73% |
| 2 | Healthcare | 13.27% |
| 3 | Financials | 12.05% |
| 4 | Consumer Discretionary | 11.3% |
| 5 | Communication Services | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Strategic Education
STRA
$1.84B
| $1.62M | ﹤0.01% |
24,372
| – | – |
|
1852
Fulgent Genetics
FLGT
$524M
| $1.62M | ﹤0.01% |
25,885
+231
| +0.9% | +$15.2K |
|
|
FSR
1853
DELISTED
Fisker Inc.
FSR
| $1.61M | ﹤0.01% |
124,970
| – | – |
|
1854
CoreCivic
CXW
$3.26B
| $1.61M | ﹤0.01% |
144,199
-3,856
| -3% | -$37.7K |
|
1855
Stride
LRN
$3.33B
| $1.61M | ﹤0.01% |
44,311
+337
| +0.8% | +$11.2K |
|
|
ECHO
1856
EchoStar
ECHO
$25.9B
| $1.61M | ﹤0.01% |
66,003
+14,538
| +28% | +$358K |
|
1857
Palomar
PLMR
$3.46B
| $1.6M | ﹤0.01% |
25,065
| – | – |
|
1858
AstraZeneca
AZN
$251B
| $1.6M | ﹤0.01% |
12,058
| – | – |
|
1859
TriMas Corp
TRS
$1.43B
| $1.6M | ﹤0.01% |
49,803
| – | – |
|
1860
Opko Health
OPK
$1.04B
| $1.6M | ﹤0.01% |
464,585
+4,366
| +0.9% | +$15.4K |
|
|
ISEE
1861
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.6M | ﹤0.01% |
94,847
+17,993
| +23% | +$266K |
|
|
BRKL
1862
DELISTED
Brookline Bancorp
BRKL
| $1.59M | ﹤0.01% |
100,795
+27,154
| +37% | +$458K |
|
1863
Core & Main
CNM
$8.67B
| $1.59M | ﹤0.01% |
65,909
+36,790
| +126% | +$865K |
|
1864
Array Technologies
ARRY
$819M
| $1.59M | ﹤0.01% |
141,418
+23,191
| +20% | +$261K |
|
|
PRA
1865
DELISTED
ProAssurance
PRA
| $1.59M | ﹤0.01% |
59,286
-9,494
| -14% | -$235K |
|
1866
DNOW Inc
DNOW
$3.01B
| $1.59M | ﹤0.01% |
144,236
-700
| -0.5% | -$6.78K |
|
1867
Standex International
SXI
$3.98B
| $1.58M | ﹤0.01% |
15,859
+5,491
| +53% | +$575K |
|
|
ADAM
1868
Adamas Trust
ADAM
$880M
| $1.58M | ﹤0.01% |
108,525
| – | – |
|
1869
The Bancorp
TBBK
$2.81B
| $1.58M | ﹤0.01% |
55,897
+485
| +0.9% | +$14K |
|
1870
Apogee Enterprises
APOG
$887M
| $1.57M | ﹤0.01% |
33,157
+6,626
| +25% | +$308K |
|
1871
Freshworks
FRSH
$3.31B
| $1.57M | ﹤0.01% |
87,600
-409,800
| -82% | -$8.34M |
|
1872
Nice
NICE
$6.01B
| $1.57M | ﹤0.01% |
+7,167
| New | +$1.74M |
|
1873
Archrock
AROC
$5.81B
| $1.57M | ﹤0.01% |
170,028
+10,234
| +6% | +$87.6K |
|
|
GCP
1874
DELISTED
GCP Applied Technologies Inc.
GCP
| $1.57M | ﹤0.01% |
49,889
-12,863
| -20% | -$408K |
|
1875
Vericel Corp
VCEL
$2.25B
| $1.56M | ﹤0.01% |
40,943
| – | – |
|
Similar funds
UBS AM's Q1 2022 Portfolio in Review
As of Q1 2022, UBS AM held 2,904 positions worth $233B, down 11% from $261B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
UBS AM withdrew a net $12.3B in Q1 2022, closing 124 positions and reducing 786 holdings. Its most notable exit was Xilinx Inc, an estimated $758M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
Against the trend, UBS AM opened a new position in Baidu worth $306M.
- UBS AM's largest Q1 2022 buy was Baidu: 2,316,525 shares worth $306M.
- UBS AM added most to Advanced Micro Devices in Q1 2022, an estimated $646M increase.
- UBS AM's biggest Q1 2022 reduction was Shopify, cutting an estimated $568M.
- UBS AM fully exited Xilinx Inc in Q1 2022, selling an estimated $758M.
- UBS AM's ten largest holdings make up 23% of its $233B portfolio in Q1 2022.
- UBS AM opened 60 new positions and closed 124 in Q1 2022.
- UBS AM's portfolio value fell 11% quarter-over-quarter to $233B.
Based on UBS AM's 13F filing for Q1 2022, filed 16 May 2022.